Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lachmann

Showing results (221-230 of 1,793) with videos related to

Pageof 180
Sort By:
Chronic Respiratory Disease|December 28, 2006
Amyloidosis and the lungH J Lachmann, P N Hawkins
Gesundheitswesen (Bundesverband Der Arzte Des Offentlichen Gesundheitsdienstes (Germany))|May 22, 2010
[Instruments of management accounting in german hospitals - potentials for competitive advantage and status quo]W Berens, M Lachmann, A Wömpener
Oral Diseases|February 6, 2009
Auto-inflammatory syndromes and oral healthC Scully, T Hodgson, H Lachmann
Sub-Cellular Biochemistry|December 11, 2012
Systemic AA amyloidosisJennifer H Pinney, Helen J Lachmann
Arzneimittel-Forschung|February 1, 1990
Pharmacokinetics and metabolism of 14C-oxaceprol in beagle dogs after intramuscular and oral administrationG Lachmann, B Siegemund, W Kusche
Die Pharmazie|January 26, 2013
Evaluation of a short stability-indicating HPLC method for diclofenac sodium gelsT Korodi, K Bukowski, B Lachmann
BMC Bioinformatics|April 18, 2012
'maskBAD'--a package to detect and remove Affymetrix probes with binding affinity differencesMichael Dannemann, Michael Lachmann, Anna Lorenc
Das Offentliche Gesundheitswesen|July 1, 1991
[The image of the public health office in the public consciousness of a small city]J Gebauer, U Lachmann, K Franz
Clinical and Experimental Immunology|January 1, 1977
A second case of human C3b inhibitor (KAF) deficiencyR A Thompson, P J Lachmann
Journal of Immunological Methods|August 3, 1987
Activation of the third component of complement (C3) detected by a monoclonal anti-C3'g' neoantigen antibody in a one-step enzyme immunoassayT E Mollnes, P J Lachmann
Pageof 180

Showing results (221-230 of 1,793) with videos related to

Sort By:
Pageof 180
Chronic Respiratory Disease|December 28, 2006
Amyloidosis and the lungH J Lachmann, P N Hawkins
Gesundheitswesen (Bundesverband Der Arzte Des Offentlichen Gesundheitsdienstes (Germany))|May 22, 2010
[Instruments of management accounting in german hospitals - potentials for competitive advantage and status quo]W Berens, M Lachmann, A Wömpener
Oral Diseases|February 6, 2009
Auto-inflammatory syndromes and oral healthC Scully, T Hodgson, H Lachmann
Sub-Cellular Biochemistry|December 11, 2012
Systemic AA amyloidosisJennifer H Pinney, Helen J Lachmann
Arzneimittel-Forschung|February 1, 1990
Pharmacokinetics and metabolism of 14C-oxaceprol in beagle dogs after intramuscular and oral administrationG Lachmann, B Siegemund, W Kusche
Die Pharmazie|January 26, 2013
Evaluation of a short stability-indicating HPLC method for diclofenac sodium gelsT Korodi, K Bukowski, B Lachmann
BMC Bioinformatics|April 18, 2012
'maskBAD'--a package to detect and remove Affymetrix probes with binding affinity differencesMichael Dannemann, Michael Lachmann, Anna Lorenc
Das Offentliche Gesundheitswesen|July 1, 1991
[The image of the public health office in the public consciousness of a small city]J Gebauer, U Lachmann, K Franz
Clinical and Experimental Immunology|January 1, 1977
A second case of human C3b inhibitor (KAF) deficiencyR A Thompson, P J Lachmann
Journal of Immunological Methods|August 3, 1987
Activation of the third component of complement (C3) detected by a monoclonal anti-C3'g' neoantigen antibody in a one-step enzyme immunoassayT E Mollnes, P J Lachmann
Pageof 180